Skip to content
MMM400400400

Drawing based on the label description. No photo yet.

“Moxifloxacin Tablets, USP are available as dull red colored, caplet shaped, film coated tablets, debossed with "M" on one side and "400" on other side”

M 400 pill

Pill with imprint M 400 is red, capsule, 17 mm and has been identified as Moxifloxacin Hydrochloride Tablets, 400 Mg 400 mg. It is supplied by Novadoz Pharmaceuticals LLC.

Moxifloxacin Hydrochloride Tablets, 400 Mg 400 mg

Imprint
M 400
Strength
400 mg
Color
Red
Shape
Capsule / oblong
Size
17 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Novadoz Pharmaceuticals LLC
NDC
72205-001, 72205-001-30, 72205-001-05, 72205-001-11, 72205-001-31, 72789-080, 72789-080-10, 70518-4312, 70518-4312-0

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Moxifloxacin Hydrochloride Tablets, 400 Mg pills and guides

What is Moxifloxacin Hydrochloride Tablets, 400 Mg used for?

Official uses from the US prescribing label

Community Acquired Pneumonia

Moxifloxacin tablets are indicated in adult patients for the treatment of Community Acquired Pneumonia caused by susceptible isolates of Streptococcus pneumoniae(including multi-drug resistant Streptococcus pneumoniae[MDRSP]), Haemophilus influenzae, Moraxella catarrhalis,methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae,or Chlamydophila pneumoniae. MDRSP isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [MIC]≥ 2 mcg/mL), 2 ndgeneration cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole.

Uncomplicated Skin and Skin Structure Infections

Moxifloxacin tablets are indicated in adult patients for the treatment of Uncomplicated Skin and Skin Structure Infections caused by susceptible isolates of methicillin- susceptible Staphylococcus aureusor Streptococcus pyogenes.

Complicated Skin and Skin Structure Infections

Moxifloxacin tablets are indicated in adult patients for the treatment of complicated Skin and Skin Structure Infections caused by susceptible isolates of methicillin- susceptible Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, or Enterobacter cloacae.

Complicated Intra-Abdominal Infections

Moxifloxacin tablets are indicated in adult patients for the treatment of Complicated Intra-Abdominal Infections (cIAI) including polymicrobial infections such as abscess caused by susceptible isolates of Escherichia coli, Bacteroides fragilis, Streptococcus anginosus, Streptococcus constellatus, Enterococcus faecalis, Proteus mirabilis, Clostridium perfringens, Bacteroides thetaiotaomicron,or Peptostreptococcusspecies.

Plague

Moxifloxacin tablets are indicated in adult patients for the treatment of plague, including pneumonic and septicemic plague, due to susceptible isolates of Yersinia pestisand prophylaxis of plague in adult patients. Efficacy studies of moxifloxacin could not be conducted in humans with plague for feasibility reasons. Therefore this indication is based on an efficacy study conducted in animals only.

Acute Bacterial Sinusitis

Moxifloxacin tablets are indicated in adult patients (18 years of age and older) for the treatment of Acute Bacterial Sinusitis (ABS) caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis. Because fluoroquinolones, including moxifloxacin tablets, have been associated with serious adverse reactions and for some patients ABS is self-limiting, reserve moxifloxacin tablets for treatment of ABS in patients who have no alternative treatment options.

Acute Bacterial Exacerbation of Chronic Bronchitis

Moxifloxacin tablets are indicated in adult patients for the treatment of Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB) caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae,methicillin-susceptible Staphylococcus aureus,or Moraxella catarrhalis. Because fluoroquinolones, including moxifloxacin tablets, have been associated with serious adverse reactions and for some patients ABECB is self-limiting, reserve moxifloxacin tablets for treatment of ABECB in patients who have no alternative treatment options.

Usage

To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin hydrochloride and other antibacterial drugs, moxifloxacin hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

From the FDA-approved label on DailyMed (published Sep 07, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows M and the other side shows 400.
  • It is red, capsule, 17 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Moxifloxacin Hydrochloride Monohydrate

Inactive: Lactose Monohydrate, Povidone K30, Anhydrous Lactose, Croscarmellose Sodium, Silicon Dioxide, Magnesium Stearate, Titanium Dioxide, Hypromelloses, Polyethylene Glycol 400, Ferric Oxide Red

Also distributed by

Pd-Rx Pharmaceuticals, Inc., Remedyrepack Inc.

Other pills with imprint M 400

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.